Jacqueline Anne Wilson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 10th Ave, Ackley, IA 50601 Phone: 641-847-2625 |
Brooke Ashton Ibeling, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 29182 County Highway D15, Ackley, IA 50601 Phone: 641-373-0734 |
Tiffany J Gramblin, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1000 10th Ave, Ackley, IA 50601 Phone: 641-847-2625 Fax: 641-847-2509 |
Jennifer Lynn Jass, A.R.N.P Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1000 10th Ave, Ackley, IA 50601 Phone: 641-847-2625 Fax: 641-847-2509 |
Courtney Carole Dinsdale, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1000 10th Ave, Ackley, IA 50601 Phone: 641-847-2625 Fax: 641-847-2509 |
News Archive
Bionovo, Inc., a drug discovery and development company focused on unmet needs in women's health and oncology, today announced that it has entered into definitive agreements to raise approximately $3.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants.
Here are a few basic facts that Americans need to keep in mind before they go to the polls, and afterward. First, most aspects of the reform do not go into effect until 2014. Second, things are indeed bad out there: The costs of medical care and insurance premiums are (still) rising, and some employers are (still) dropping coverage. But for that, you should blame the long-standing health care crisis and the current bad economy. Health reform is supposed to help with these problems (10/23).
The vaccine that protects against cancer-causing types of human papillomavirus (HPV) also prevents an uncommon but incurable childhood respiratory disease, according to a new study published in The Journal of Infectious Diseases.
WellCare Health Plans, Inc. (NYSE: WCG) announced it will cover the full cost of administration of the H1N1 vaccine as a preventative care benefit for Medicare Advantage, Medicare private fee-for-service (PFFS) and Medicaid plan members when it becomes available to the public.
Alder Biopharmaceuticals Inc. today announced it will receive a $15 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2b clinical trial in rheumatoid arthritis for ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6).
› Verified 5 days ago